Werkgroep Cardiologische centra Nederland English

CHF fase I BMS (Includerend)

A Randomized, Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986224 in Healthy Subjects and Chronic HFrEF
Middel
BMS-986224
Populatie
hartfalen
Fase
Ib
Jaar aanvang
2017